Commentary |

Risk Stratification and Therapeutic Decision Making in Acute Coronary Syndromes

E. Magnus Ohman, MD; Christopher B. Granger, MD; Robert A. Harrington, MD; Kerry L. Lee, PhD
JAMA. 2000;284(7):876-878. doi:10.1001/jama.284.7.876.
Text Size: A A A
Published online


Management of acute coronary syndromes has advanced considerably during recent years, similar to the evolution in treatment of acute myocardial infarction (MI) in the 1980s. Then, fibrinolytic and aspirin therapy were shown to reduce mortality substantially.1 Although these therapies first were applied to all patients with suspected MI,1 those with ST-segment elevation or left bundle-branch block were shown to derive most, if not all, of the benefit.2 Accelerated tissue-type plasminogen activator (tPA) then was found to be superior to streptokinase in the Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO-I) trial, with a relative 14% reduction in 30-day mortality.3 Mortality models suggested that tPA treatment independently predicted better outcomes, consistent across patient subgroups regardless of absolute risk.4 Without a heterogeneous treatment effect, the interpretation was that almost all patients with MI would benefit from tPA treatment.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 80

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles

The Rational Clinical Examination
Evidence Summary and Review 2

The Rational Clinical Examination
Multivariate Findings for ACI Syndromes